A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

NCT06671483 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1088

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Zasocitinib
DRUG: Active Comparator
DRUG: Placebo

Sponsor

Takeda